Yunxia Tao Selected Research

Drug Therapy (Chemotherapy)

1/2021	Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy.
1/2020	MiR-106b inhibition suppresses inflammatory bone destruction of wear debris-induced periprosthetic osteolysis in rats.
6/2015	[A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunxia Tao Research Topics

Disease

9	Osteolysis 05/2022 - 03/2016
7	Bone Resorption 05/2022 - 10/2016
7	Inflammation (Inflammations) 01/2021 - 10/2016
5	Polycystic Kidney Diseases (Polycystic Kidney Disease) 09/2012 - 01/2005
3	Neoplasms (Cancer) 12/2020 - 12/2009
3	Cysts 09/2012 - 01/2005
3	Disease Progression 09/2012 - 01/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2022
2	Osteoporosis 01/2022 - 01/2017
2	Rheumatoid Arthritis 01/2019 - 01/2019
2	Autosomal Dominant Polycystic Kidney (ADPKD) 09/2007 - 03/2005
2	Acute Kidney Injury (Acute Renal Failure) 01/2007 - 05/2005
2	Renal Insufficiency (Renal Failure) 05/2005 - 01/2005
1	Brain Neoplasms (Brain Tumor) 12/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2022
1	Exanthema (Rash) 01/2022
1	Hypercholesterolemia 01/2022
1	Hypertriglyceridemia 01/2022
1	Lung Neoplasms (Lung Cancer) 06/2021
1	Lymphoma (Lymphomas) 05/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021
1	Prosthesis Failure 01/2020
1	Osteoarthritis 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Hyperplasia 01/2019
1	Congenital Abnormalities (Deformity) 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Scoliosis 01/2018
1	Intervertebral Disc Degeneration 01/2018
1	Joint Diseases (Joint Disease) 01/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Hodgkin Disease (Hodgkin's Disease) 06/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2011
1	Necrosis 11/2011
1	Breast Neoplasms (Breast Cancer) 12/2009

Drug/Important Bio-Agent (IBA)

8	TitaniumIBA 05/2022 - 10/2016
4	CytokinesIBA 01/2019 - 05/2005
3	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2005
2	Immune Checkpoint InhibitorsIBA 12/2022 - 12/2020
2	Anaplastic Lymphoma KinaseIBA 07/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 06/2021 - 01/2019
2	RANK LigandIBA 01/2017 - 01/2017
2	CateninsIBA 01/2017 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2007
2	Metalloproteases (Metalloproteinases)IBA 09/2012 - 12/2009
2	Caspase 3 (Caspase-3)IBA 04/2008 - 05/2005
2	CaspasesIBA 05/2005 - 03/2005
1	AntioxidantsIBA 05/2022
1	ensartinibIBA 01/2022
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	lorlatinibIBA 01/2022
1	25-hydroxyvitamin DIBA 05/2021
1	hydroxide ionIBA 05/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Advanced Glycation End ProductsIBA 01/2019
1	Exenatide (Byetta)FDA Link 01/2019
1	NADPH Oxidase 4IBA 01/2019
1	Tartrate-Resistant Acid PhosphataseIBA 01/2019
1	LigandsIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	Cathepsin KIBA 01/2019
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2019
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2019
1	SR 144528IBA 01/2019
1	ProlactinIBA 01/2018
1	Lithium ChlorideIBA 10/2017
1	GlucocorticoidsIBA 01/2017
1	OsteoprotegerinIBA 01/2017
1	MelatoninIBA 01/2017
1	theaflavin-3,3'-digallateIBA 01/2017
1	TeaIBA 01/2017
1	StrontiumIBA 10/2016
1	icariinIBA 03/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2012
1	CollagenIBA 09/2012
1	Doxycycline (Periostat)FDA LinkGeneric 09/2012
1	Collagen Type I (Type I Collagen)IBA 09/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011
1	Inhibitor of Differentiation Protein 1IBA 12/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2007
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2007

Therapy/Procedure

3	Arthroplasty 03/2022 - 03/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 06/2015
2	Replacement Arthroplasty 05/2022 - 01/2020
2	Therapeutics 01/2020 - 01/2016
1	Punctures 01/2018
1	Diskectomy (Discectomy) 01/2018
1	Reoperation 01/2017